-
What value is Heart Lung Machine Market expected to touch by 2033?
The Heart Lung Machine Market is expected to reach USD 329.88 Million by 2033.
-
What CAGR is the Heart Lung Machine Market expected to exhibit by 2033?
The Heart Lung Machine Market is expected to exhibit a CAGR of 3.3% by 2033.
-
What are the driving factors of the Heart Lung Machine Market?
Rising pervasiveness of cardiovascular and pneumonic illnesses and reception of cutting-edge gadgets across significant hospitals to expand the market growth
-
What are the key Heart Lung Machine Market segments?
The key market segmentation, which includes, based on type, the Heart Lung Machine Market is Single Roller Pump Heart Lung Machine, Double Roller Pump Heart Lung Machine. Based on application, the Heart Lung Machine Market is classified as Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other.
-
Who are some of the prominent players in the Heart Lung Machine industry?
Top players in the sector include LivaNova (Sorin) (U.K.), Getinge (Maquet) (Sweden), Medtronic (U.S.), Terumo CV Group (Japan), Braile Biomedica (Brazil), Tianjin Medical (China).
-
Which region is leading in the Heart Lung Machine Market?
North America is currently leading the Heart Lung Machine Market.